Results 131 to 140 of about 14,856,300 (187)
Nodal peripheral T-cell lymphoma in Finland between 2007 and 2019: Incidence, late morbidity and survival. [PDF]
Br J HaematolPartanen A +7 more
europepmc +1 more source
A Finnish nationwide population-based study on the survival of patients with peripheral T-cell lymphoma. [PDF]
Sci RepReunamo T +7 more
europepmc +1 more source
Population Pharmacokinetics of Valemetostat and Exposure-Response Analyses of Efficacy and Safety in Patients with Relapsed/Refractory Peripheral T-Cell Lymphoma. [PDF]
J Clin PharmacolInoue H +7 more
europepmc +1 more source
Cure of a CD20-positive peripheral T-cell lymphoma-NOS with CHOPE regimen plus surgery a case report and literature review. [PDF]
Front Med (Lausanne)Chi C, Wang S, Xu M, Shi Y, Ran X.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Hematological Oncology, 2023
AbstractThe treatment of peripheral T‐cell lymphomas is challenging, as they often display a severe prognosis and lack effective treatment strategies. We will try to answer three burning questions: can we differentiate the initial treatment based on the histotype and the clinical presentation of peripheral T‐cell lymphoma patients?
Broccoli A., Zinzani P. L.
openaire +3 more sources
AbstractThe treatment of peripheral T‐cell lymphomas is challenging, as they often display a severe prognosis and lack effective treatment strategies. We will try to answer three burning questions: can we differentiate the initial treatment based on the histotype and the clinical presentation of peripheral T‐cell lymphoma patients?
Broccoli A., Zinzani P. L.
openaire +3 more sources
Pathogenesis of Peripheral T Cell Lymphoma
Annual Review of Pathology: Mechanisms of Disease, 2018 Peripheral T cell lymphomas (PTCLs) are highly heterogeneous tumors, displaying distinct clinical and biological features. The pathogenesis and normal counterpart of such entities have been elusive for decades. Recent studies have, however, disclosed key mechanisms of peripheral T cell transformation, including (a) the deregulation of signaling ...
Elizabeth Margolskee, Marco Pizzi
exaly +4 more sources
Cancer and Metastasis Reviews, 1988
Since the discovery of human T-cell leukemia virus type 1 (HTLV-1) in patients with adult T-cell leukemia/lymphoma (ATLL), malignant neoplasms of mature (peripheral) T lymphocytes have attracted a great deal of attention. This type of neoplasm is more common in Japan than in Western countries, and may show distinct clinical pictures such as ...
S, Watanabe, K, Mukai, M, Shimoyama
openaire +2 more sources
Since the discovery of human T-cell leukemia virus type 1 (HTLV-1) in patients with adult T-cell leukemia/lymphoma (ATLL), malignant neoplasms of mature (peripheral) T lymphocytes have attracted a great deal of attention. This type of neoplasm is more common in Japan than in Western countries, and may show distinct clinical pictures such as ...
S, Watanabe, K, Mukai, M, Shimoyama
openaire +2 more sources
The spectrum of peripheral T-cell lymphomas
Current Opinion in Hematology, 2009This review summarizes recent progress that has advanced our understanding of the pathobiology and prognosis of peripheral T-cell lymphomas including the changes introduced to the updated World Health Organization classification of lymphoid neoplasms.The International Peripheral T-Cell Lymphoma Project was a large collaborative project, highlighting ...
Hilary, O'leary, Kerry J, Savage
openaire +2 more sources
Peripheral T Cell Lymphoma: an Overview
Leukemia & Lymphoma, 1990Peripheral T cell lymphoma (PTCL) is a term that encompasses a wide range of histological subtypes of Non-Hodgkin's lymphoma which arise from mature or post-thymic T lymphocytes. These tumours account for 10-20% of all cases of non-Hodgkin's lymphoma in the Western World.
P A, Hall, M A, Richards
openaire +2 more sources